Zurich Cantonal Bank
DAWN

Zurich Cantonal Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Zurich Cantonal Bank’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$864K Buy
40,315
+1,795
+5% +$25.3K ﹤0.01% 1517
2025
Q4 		$359K Buy
38,520
+14,425
+60% +$121K ﹤0.01% 1960
2025
Q3 		$170K Sell
24,095
-8,844
-27% -$60.9K ﹤0.01% 2260
2025
Q2 		$214K Buy
32,939
+18,670
+131% +$128K ﹤0.01% 2103
2025
Q1 		$113K Hold
14,269
– – ﹤0.01% 2339
2024
Q4 		$181K Buy
14,269
+7,291
+104% +$101K ﹤0.01% 2194
2024
Q3 		$97.2K Hold
6,978
– – ﹤0.01% 2428
2024
Q2 		$96.2K Hold
6,978
– – ﹤0.01% 2389
2024
Q1 		$115K Hold
6,978
– – ﹤0.01% 2326
2023
Q4 		$102K Sell
6,978
-2,277
-25% -$27.6K ﹤0.01% 2439
2023
Q3 		$114K Hold
9,255
– – ﹤0.01% 2298
2023
Q2 		$111K Buy
+9,255
New +$121K ﹤0.01% 2303

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Zurich Cantonal Bank's DAWN Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Day One Biopharmaceuticals (DAWN) stake by 4.7% in Q1 2026, buying an estimated $25.3K and bringing the position to 40,315 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Zurich Cantonal Bank first reported a position in DAWN in Q2 2023 and has held it in 12 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Zurich Cantonal Bank held 40,315 shares of Day One Biopharmaceuticals worth $864K as of Q1 2026.
  • Zurich Cantonal Bank bought 1,795 Day One Biopharmaceuticals shares in Q1 2026, an estimated $25.3K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1517 holding.
  • Zurich Cantonal Bank first reported a position in Day One Biopharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.